Monique Roobol, PhD

Monique Roobol, PhD

Monique Roobol is Professor Decision Making in Urology and the Head of the scientific research office within the Department of Urology at Erasmus Medical Centre Rotterdam, The Netherlands. She has a masters and a PhD degree in epidemiology.

The last thirty years have been completely dedicated to research on the early detection of prostate cancer. Next to her significant contribution to the European Randomized study of Screening for Prostate Cancer, she co-developed the “Rotterdam Prostate Cancer Risk calculator, a multi-step risk analysis tools to guide laymen and physician in decision making at diagnosis and the study on active surveillance. (PRIAS: Prostate Cancer Research International Active Surveillance.

The scientific research office performs and supports several clinical and population-based screening studies. On average five PhD students are working under Prof. Roobol’s guidance. She is now the PI of ERSPC and co-PI of PRIAS and the Movember Global Action Plan-3 (active surveillance). Since 2018 she is part of the PIONEER European network for big data in prostate cancer. She is board member of the ERSPC Foundation, and the  chairwoman of the Dutch Prostate Cancer Research Foundation (SWOP).

Prof.  Roobol has (co)-authored over 350 scientific publications, book chapters and reviews. She is an advisory board member of several major trials related to prostate cancer

Prof. Roobol’s research has been awarded with several prices, such as the bi-annual “van Stockum prize” from the Dutch Urological Association for best thesis, the EAU best clinical paper of the year 2009, the European Urology Platinum Award 2011 and 2018 and the BJUI best urological mobile application award 2015.

Talks by Monique Roobol, PhD

Update on PRAISE-U Project – European Union Initiative in PC Screening

Monique Roobol, PhD, focuses on prostate cancer screening practices in Europe, highlighting recent developments, ongoing initiatives, and future prospects. In 2022, the European Union (EU) updated its cancer screening recommendations, formally including prostate cancer alongside breast, lung, colorectal, and gastric cancers, spurring momentum for organized prostate cancer screening initiatives across Europe.

In this 11-minute presentation, Dr. Roobol shares the PRAISE-U initiative, launched following the EU’s recommendations. This initiative seeks to pilot and evaluate risk-based screening strategies across all EU member countries, including Spain, Ireland, Lithuania, and Poland.

Read More

Join the GRU Community

- Why Join? -